Hudson Executive Capital LP, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 29,386 shares at $62.50 ($1.8M) on 2019-10-16, disclosed to the SEC on 2019-10-18.
Open-market sale of $1.8M EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.50 | 102 | $6K | 0.3% |
| 2 | $62.58 | 13,842 | $866K | 47.1% |
| 3 | $62.58 | 13,842 | $866K | 47.1% |
| 4 | $62.61 | 1,600 | $100K | 5.4% |
| Total | $62.58 avg | 29,386 | $1.8M | 100% |
| Filing → |
| CATM | BUY | 2020-06-29 | $8.6M | — | Filing → |
| CATM | BUY | 2020-06-23 | $8.2M | — | Filing → |
| CATM | BUY | 2020-05-19 | $1.5M | — | Filing → |